NCT06438536

Brief Summary

The goal of this clinical trial is to learn if a new Virtual Reality-based intervention will be effective in treating social cognitive challenges in adults with autism. The main questions it aims to answer are:

  1. 1.Is Virtual Reality-based social cognitive training effective in reducing social cognitive deficits and improving psychosocial functioning, quality of life, and clinical symptoms in adults with ASD?
  2. 2.Is Virtual Reality-based social cognitive training cost-effective?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
May 2024Jul 2026

Study Start

First participant enrolled

May 2, 2024

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

June 3, 2024

Status Verified

May 1, 2024

Enrollment Period

2.2 years

First QC Date

May 23, 2024

Last Update Submit

May 30, 2024

Conditions

Keywords

Randomized clinical trial (RCT)Virtual Reality (VR)Social cognitive trainingCognitive remediationDigital intervention

Outcome Measures

Primary Outcomes (1)

  • Social Responsiveness Scale, Adult Version, Self-report

    The primary outcome is level of social impairment is measured by the Social Responsiveness Scale, Second Edition, Adult version, Self-report (SRS-2A) at cessation of treatment at 3-months. SRS-2A measures the presence and severity of social impairment in everyday life. The SRS-2A is a commonly used measure in autism spectrum research and has demonstrated good reliability and validity. SRS-2A is a 65-item rating scale, scored on on a 4-point Likert Scale (0-3). Each item is scaled from 0 (never true) to 3 (almost always true), generating a total score ranging from 0 to 195. The SRS-2A is provides a continuous measure of social impairment, where a higher score reflects a greater degree of difficulties with social interactions in everyday life. Follow-up assessments will comprise ratings of the previous two-week period.

    Baseline, 3 month follow-up and 6 month follow-up

Secondary Outcomes (5)

  • Social Responsiveness Scale, Adult Version, Informant Report

    Baseline, 3 month follow-up and 6 month follow-up

  • Social Interaction Anxiety Scale (SIAS)

    Baseline, 3 month follow-up and 6 month follow-up

  • The Empathy Quotient

    Baseline, 3 month follow-up and 6 month follow-up

  • The High Risk Social Challenge Task (HiSoC)

    Baseline, 3 month follow-up and 6 month follow-up

  • Emotion Recognition Task (CANTAB ERT)

    Baseline, 3 month follow-up and 6 month follow-up

Other Outcomes (25)

  • CAT-Q (Camouflaging Autistic Traits Questionnaire)

    Baseline, 3 month follow-up and 6 month follow-up

  • SR-AS (Questionnaire on sensory reactions)

    Baseline, 3 month follow-up and 6 month follow-up

  • Beck Depression Inventory (BDI)

    Baseline, 3 month follow-up and 6 month follow-up

  • +22 more other outcomes

Study Arms (2)

Virtual Reality-based Social Cognitive Training (VRSCT)

EXPERIMENTAL

Patients in the experimental group will be offered 10 individual sessions of targeted, virtual reality assisted psychotherapy embedded in cognitive behavioral therapy (CBT), that aims at enhancing social cognition and daily life functioning. If the patient consents, two additional sessions will be offered in which the patient's relatives are invited to participate (one in the beginning of treatment and one at the end of treatment). The aim of the relative involvement is to enhance transfer from the therapy to the patients daily life. The treatment will be conducted by psychologists with an extensive knowledge in providing virtual reality assisted therapy. The treatment is manualized, and the therapists will receive ongoing supervision by a senior clinician having ≥ 25 years of experience in conducting assessment, treatment, and research with the autism spectrum population.

Behavioral: Virtual Reality-based Social Cognitive Training

Treatment as Usual (TAU)

NO INTERVENTION

The treatment-as-usual (TAU) group will receive the standard treatment offered to adults diagnosed with ASD in Denmark. This commonly consists of four psychoeducational sessions as well as limited supportive counseling. Some adults with ASD also receive practical help in daily life situations in community settings. The TAU will be mapped upon trial completion.

Interventions

Virtual reality assisted social cognitive training embedded in cognitive behavioral therapy, that aims at enhancing social cognition and daily life functioning.

Virtual Reality-based Social Cognitive Training (VRSCT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 18 years or older
  • Ability to give informed consent
  • Diagnosis of an autism spectrum disorder (ICD-10 code F84.0; F84.1; F84.5; F84.8)
  • T-score on SRS-A self-report ≥ 60

You may not qualify if:

  • Rejecting informed consent
  • A diagnosis of organic brain disease
  • Intellectual disability (IQ ˂ 70)
  • A command of spoken Danish or English inadequate for engaging in therapy
  • ADHD-diagnosis with untreated symptoms
  • Displaying an imminent homicidal or suicidal risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Copenhagen Research Centre for Mental Health (CORE), Mental Health Centre Copenhagen, Mental Health Services in the Capital Region, Denmark

Copenhagen, Hellerup, 2900, Denmark

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Louise B. Glenthøj, DrMSc

    Copenhagen Research Centre for Mental Health (CORE), Mental Health Centre Copenhagen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Johannes Andresen, MSc Psych

CONTACT

Alberte Cathrine E. Jeppesen, MSc Psych

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Stratified block randomization with concealed randomization sequences will be conducted after baseline assessment. Independent assessors blinded to the treatment will evaluate outcomes. Analysis of outcomes will be carried out following the intention-to-treat principles.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study is a high-quality randomized, assessor-blinded parallel-groups superiority clinical trial fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 140 adults with ASD will be allocated to receive either 12 weeks of Virtual Reality-based Social Cognitive Training (VRSCT) + treatment as usual (TAU) or TAU. All participants will be assessed at baseline and at 3- and 6-months post-baseline.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DMSc, PhD, psychologist with specialization in psychiatry and specialist in psychotherapy

Study Record Dates

First Submitted

May 23, 2024

First Posted

June 3, 2024

Study Start

May 2, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

June 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations